Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, milder form of amyotrophic lateral sclerosis. It is characterized by a slowly progressive clinical course. Signs and symptoms include muscle weakness, atrophy, and fasciculation.
Biomarker and diagnostic research for progressive muscular atrophy has been reported in the published literature.
57 clinical trials registered, 22 recruiting. Interventions under study include other interventions, drug therapy, medical devices, and procedural interventions. Pipeline includes 3 PHASE4, 4 PHASE3, 2 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT07047144](https://clinicaltrials.gov/study/NCT07047144) |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 6:21 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy |
PHASE2 |
Scholar Rock, Inc. |
RECRUITING |
[NCT06396325](https://clinicaltrials.gov/study/NCT06396325) | A Registry Based Randomized-Controlled Trial of an Upper Limb Exergaming Intervention for Children and Adolescents With Spinal Muscular Atrophy | NA | Maryam Oskoui, MD, MSc, FRCPC, FAAN | RECRUITING |
[NCT07444476](https://clinicaltrials.gov/study/NCT07444476) | A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam | PHASE3 | Biogen | RECRUITING |
[NCT06321965](https://clinicaltrials.gov/study/NCT06321965) | Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy | NA | Hospices Civils de Lyon | RECRUITING |
[NCT05204017](https://clinicaltrials.gov/study/NCT05204017) | Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS | — | University of Alberta | RECRUITING |
189 publications have been identified in PubMed for progressive muscular atrophy. Research spans Review / Meta-Analysis (32%), Epidemiology / Natural History (23%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 61 | 32% |
Disease patterns and progression | 44 | 23% |
Laboratory research | 28 | 15% |
New treatment approaches | 21 | 11% |
Testing and diagnosis research | 16 | 8% |
Patient case studies | 11 | 6% |
Clinical study results | 8 | 4% |
Valentini I (2026). [PMID: 40569556](https://pubmed.ncbi.nlm.nih.gov/40569556/). *Eur J Health Econ*. [Basic Science / Preclinical]
Gerstner F (2026). [PMID: 40966716](https://pubmed.ncbi.nlm.nih.gov/40966716/). *Brain*. [Basic Science / Preclinical]
Ramroop H (2026). [PMID: 33085325](https://pubmed.ncbi.nlm.nih.gov/33085325/). *Unknown Journal*. [Epidemiology / Natural History]
Patel R (2026). [PMID: 41791198](https://pubmed.ncbi.nlm.nih.gov/41791198/). *Pediatr Neurol*. [Review / Meta-Analysis]
Rajkumar I (2026). [PMID: 41756551](https://pubmed.ncbi.nlm.nih.gov/41756551/). *Radiology case reports*. [Case Report / Case Series]
Drouin E (2026). [PMID: 41855303](https://pubmed.ncbi.nlm.nih.gov/41855303/). *European neurology*. [Review / Meta-Analysis]
Belančić A (2026). [PMID: 41789956](https://pubmed.ncbi.nlm.nih.gov/41789956/). *Br J Clin Pharmacol*. [Review / Meta-Analysis]
Sun J (2026). [PMID: 41655958](https://pubmed.ncbi.nlm.nih.gov/41655958/). *Am J Pathol*. [Review / Meta-Analysis]
Arora RD (2026). [PMID: 32809609](https://pubmed.ncbi.nlm.nih.gov/32809609/). *Unknown Journal*. [Epidemiology / Natural History]
Haque US (2026). [PMID: 41028674](https://pubmed.ncbi.nlm.nih.gov/41028674/). *Methods Mol Biol*. [Basic Science / Preclinical]